drugset / Trial / NCT03576235
Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients
Completed
80 enrolled
Seoul National University Boramae Hospital
Chungnam National University Hospital · collabDongGuk University · collabEwha Womans University Mokdong Hospital · collabGachon University Gil Medical Center · collabKyungpook National University Hospital · collabSeoul National University Bundang Hospital · collabSeoul National University Hospital · collabSeverance Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this study (SNUG trial), the investigators aim to investigate the anti-pruritic effect of PG102P in comparison with placebo in 80 patients undergoing HD.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2019-01-31
- Completion
- 2019-03-30
Publications
- Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev. 2020 Dec 7;12(12):CD011393. doi: 10.1002/14651858.CD011393.pub2.
- Kim YC, Park JY, Oh S, Cho JH, Chang JH, Choi DE, Park JT, Lee JP, Kim S, Kim DK, Ryu DR, Lim CS. Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial. Trials. 2019 Nov 28;20(1):651. doi: 10.1186/s13063-019-3753-1.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PG102P | Unknown | 1.5 g | — |
Indications
No indication recorded.